Ruijin Hospital
Shanghai · CN · healthcare
Principaux domaines
Évolution annuelle
Publications récentes
Tumor-derived palmitate S-palmitoylates METTL16 to hardwire an immunosuppressive metabolic-epitranscriptomic circuitry in macrophages
Cu-deficient Cu–Fe Prussian blue analogues enable phosphate/GSH-coupled redox remodeling for catalytic/sonodynamic cancer therapy
De Zhao, Yun Song, 项时昊, Hong Hu et autres
Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis
Wangyang Meng, Tong Lu, Mingyuan Du, Xin Dai et autres
Activation of lung megakaryocyte α7 nAChR exacerbates allergic airway inflammation via IL-33/p38 MAPK signaling
Hang Wu, Rujia Tao, Shitao Xie, Ruhong Zhou et autres
Correlation Between the Extent of Lateral Neck Lymph Node Dissection and Postoperative Parathyroid Function in Papillary Thyroid Carcinoma
Yi Shen, Xiaoen Li, Yupan Chen, Xujie Han
Integrated machine learning and clinical validation identify COL21A1 as a potential biomarker for sarcopenia
Zhi Wang, Yidong Zhu, Ping Jiang, Yajuan Guo et autres
Association between apolipoprotein B/A1 ratio with heart failure severity in HFrEF, HFmrEF, and HFpEF
Qing Zhou, Yan Ren, Yang Dai, Shuai Chen et autres
ZMYND11::MBTD1-rearranged acute myeloid leukemia in Chinese adolescents and adults: clinicopathologic features and clinical outcomes
Saisai Li, Yuanyuan Chen, Xuehang Fu, Xiangqin Weng et autres
Aroyl diheterocyclic pyrrole (ARDHEP)@PLGA nanoparticles suppress human gastric cancer growth by modulating chromatin accessibility to activate the ZNF320-mediated cytokine-cytokine receptor pathway
Zhentian Ni, Zeyu Cui, Zhenqiang Wang, Lian Yang et autres
Real-world efficacy and safety of upadacitinib in difficult-to-treat Crohn’s disease: a 24-week multicenter study from China
Zile Zhang, Shuowen Zhang, Wensong Ge, Yue Li et autres
Plasma metabolic fingerprinting identifies phenylalanine as a mortality biomarker in elderly ARDS patients
Yanyan Li, Jing Xu, Boshun Zhang, Yida Huang et autres
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.